Atezolizumab for locally advanced or metastatic PD-L1-selected NSCLC

Dr Benjamin Besse - Institut Gustave Roussy, Villejuif, France
Atezolizumab for locally advanced or metastatic PD-L1-selected NSCLC ( Dr Benjamin Besse - Institut Gustave Roussy, Villejuif, France )
30 Sep 2015

Rova-T: First ‘targeted’ treatment for small cell lung cancer shows promise

Dr Catherine Pietanza - Memorial Sloan Kettering Cancer Center, New York, USA
Rova-T: First ‘targeted’ treatment for small cell lung cancer shows promise ( Dr Catherine Pietanza - Memorial Sloan Kettering Cancer Center, New York, USA )
28 Sep 2015

Atezolizumab monotherapy vs docetaxel in 2nd and 3rd line NSCLC

Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium
Atezolizumab monotherapy vs docetaxel in 2nd and 3rd line NSCLC ( Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium )
28 Sep 2015

Latest in lung cancer from ECC 2015

Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany
Latest in lung cancer from ECC 2015 ( Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany )
28 Sep 2015

Tackling global radiotherapy shortfall could save millions of lives and boost the economy of poorer countries

Prof Rifat Atun - Harvard University, Boston, USA
Tackling global radiotherapy shortfall could save millions of lives and boost the economy of poorer countries ( Prof Rifat Atun - Harvard University, Boston, USA )
26 Sep 2015

The p-medicine project and ECRIN

Jacques Demotes - ECRIN
The p-medicine project and ECRIN ( Jacques Demotes - ECRIN )
2 Sep 2015

Highlights of the p-medicine project

Highlights of the p-medicine project (  )
2 Sep 2015

Banking on biomarkers – improving the diagnosis of early stage NSCLC

Dr Harvey Pass - New York University Langone Medical Center, New York, USA
Banking on biomarkers – improving the diagnosis of early stage NSCLC ( Dr Harvey Pass - New York University Langone Medical Center, New York, USA )
6 Jul 2015

Moving precision medicine for lung cancer into the adjuvant setting

Dr Don Gibbons - The University of Texas MD Anderson Cancer Center, Houston, USA
Moving precision medicine for lung cancer into the adjuvant setting ( Dr Don Gibbons - The University of Texas MD Anderson Cancer Center, Houston, USA )
6 Jul 2015

SPRING – rolling tri-therapy combinations of targeted drugs in second line of metastatic NSCLC

Prof Razelle Kurzrock - University of California, San Diego, USA
SPRING – rolling tri-therapy combinations of targeted drugs in second line of metastatic NSCLC ( Prof Razelle Kurzrock - University of California, San Diego, USA )
3 Jul 2015

SPECTAlung: improving clinical trial access for patients with thoracic tumours

Dr Jessica Menis and Dr Benjamin Besse
SPECTAlung: improving clinical trial access for patients with thoracic tumours ( Dr Jessica Menis and Dr Benjamin Besse )
3 Jul 2015

PDL1 expression in thymic tumours

Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA
PDL1 expression in thymic tumours ( Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA )
16 Jun 2015